SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 133.57.
Share Price | ₹172.2 | Jul 31,2025 |
Market Cap | ₹4,308.9 Cr | |
Earnings-TTM | ₹32.3 Cr | TTM-Consolidated Results |
Price/Earnings | 133.57x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,308.9 Cr] as on Jul 31,2025
(/) Earnings [ ₹32.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 133.57x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 133.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 58.69x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 62.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2025 at 149.64x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SEQUENT SCIENTIFIC | 32.26 | 133.57 | 4,308.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.27 | 409,219.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.98 | 175,227.0 |
CIPLA LTD | 5,406.81 | 23.22 | 125,541.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 63.26 | 126,643.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.52 | 106,063.0 |
MANKIND PHARMA LTD | 2,003.22 | 52.90 | 105,978.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.15 | 97,604.7 |
LUPIN LTD | 3,306.26 | 26.65 | 88,097.4 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.85 | 66,266.6 |
ABBOTT INDIA LTD | 1,414.44 | 51.71 | 73,145.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.52x |
Max industry PE | 133.57x |
Median industry PE | 37.27x |
Average industry PE | 47.92x |
You may also like the below Video Courses